Haisma HJ - Search Results

1

Autologous stem cell therapy in knee osteoarthritis: a systematic review of randomised controlled trials.

Wiggers TG, Winters M, Van den Boom NA, Haisma HJ, Moen MH. Wiggers TG, et al. Among authors: haisma hj. Br J Sports Med. 2021 Oct;55(20):1161-1169. doi: 10.1136/bjsports-2020-103671. Epub 2021 May 26. Br J Sports Med. 2021. PMID: 34039582 Review.

2

Efficacy of Stem Cell Therapy for Tendon Disorders: A Systematic Review.

van den Boom NAC, Winters M, Haisma HJ, Moen MH. van den Boom NAC, et al. Among authors: haisma hj. Orthop J Sports Med. 2020 Apr 30;8(4):2325967120915857. doi: 10.1177/2325967120915857. eCollection 2020 Apr. Orthop J Sports Med. 2020. PMID: 32440519 Free PMC article. Review.

3

No evidence for the use of stem cell therapy for tendon disorders: a systematic review.

Pas HIMFL, Moen MH, Haisma HJ, Winters M. Pas HIMFL, et al. Among authors: haisma hj. Br J Sports Med. 2017 Jul;51(13):996-1002. doi: 10.1136/bjsports-2016-096794. Epub 2017 Jan 11. Br J Sports Med. 2017. PMID: 28077355 Review.

4

Stem cell injections in knee osteoarthritis: a systematic review of the literature.

Pas HI, Winters M, Haisma HJ, Koenis MJ, Tol JL, Moen MH. Pas HI, et al. Among authors: haisma hj. Br J Sports Med. 2017 Aug;51(15):1125-1133. doi: 10.1136/bjsports-2016-096793. Epub 2017 Mar 3. Br J Sports Med. 2017. PMID: 28258177 Review.

5

Gene doping: an overview and current implications for athletes.

van der Gronde T, de Hon O, Haisma HJ, Pieters T. van der Gronde T, et al. Among authors: haisma hj. Br J Sports Med. 2013 Jul;47(11):670-8. doi: 10.1136/bjsports-2012-091288. Epub 2013 Jan 15. Br J Sports Med. 2013. PMID: 23322893 Review.

6

Gene doping.

Haisma HJ, de Hon O. Haisma HJ, et al. Int J Sports Med. 2006 Apr;27(4):257-66. doi: 10.1055/s-2006-923986. Int J Sports Med. 2006. PMID: 16572366 Review.

7

Targeted elimination of activated hepatic stellate cells by an anti-epidermal growth factor-receptor single chain fragment variable antibody-tumor necrosis factor-related apoptosis-inducing ligand (scFv425-sTRAIL).

Arabpour M, Poelstra K, Helfrich W, Bremer E, Haisma HJ. Arabpour M, et al. Among authors: haisma hj. J Gene Med. 2014 Sep-Oct;16(9-10):281-90. doi: 10.1002/jgm.2776. J Gene Med. 2014. PMID: 25088657

8

A next-generation sequencing method for gene doping detection that distinguishes low levels of plasmid DNA against a background of genomic DNA.

de Boer EN, van der Wouden PE, Johansson LF, van Diemen CC, Haisma HJ. de Boer EN, et al. Among authors: haisma hj. Gene Ther. 2019 Aug;26(7-8):338-346. doi: 10.1038/s41434-019-0091-6. Epub 2019 Jul 11. Gene Ther. 2019. PMID: 31296934 Free PMC article.

9

Pharmacological interventions for improving adenovirus usage in gene therapy.

Haisma HJ, Bellu AR. Haisma HJ, et al. Mol Pharm. 2011 Feb 7;8(1):50-5. doi: 10.1021/mp100310h. Epub 2010 Nov 11. Mol Pharm. 2011. PMID: 20979428 Review.

10

Targeted cancer gene therapy: the flexibility of adenoviral gene therapy vectors.

Rots MG, Curiel DT, Gerritsen WR, Haisma HJ. Rots MG, et al. Among authors: haisma hj. J Control Release. 2003 Feb 21;87(1-3):159-65. doi: 10.1016/s0168-3659(02)00360-7. J Control Release. 2003. PMID: 12618032 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

150 results

Search Page